1. Hsiao, W. W.*; Lama, X. M.; Le, T. N.; Cheng, C. A.*; Chang, H. C. Exploring nanodiamonds: leveraging their dual capacities for anticancer photothermal therapy and temperature sensing, Nanoscale 2024, 16, 14994.

2. Cheng, C. A.* Before Translating Extracellular Vesicles into Personalized Diagnostics and Therapeutics: What We Could Do, Mol. Pharmaceutics. 2024, 21, 6, 2625–2636. (Selected as Cover Story, also featured in Voices (Mol. Pharmaceutics 2024, 21, 7, 3082–3083))

3. Cheng, C. A.*; Hou, K. C.; Hsu, C. W.; Chiang, L. C. Ultrasensitive and High-Resolution Protein Spatially Decoding Framework for Tumor Extracellular Vesicles, Adv. Sci. 2024, 11, 2304926. (Selected as Front Cover Story)

4. Cheng, C. A.*; Chiang, L. C.; Chu, Y. S. Integrated Pipeline for Ultrasensitive Protein Detection in Cancer Nanomedicine, RSC Adv. 2023, 13, 14685–14697.

5. Sherman, A. C.; Cheng, C. A.; Swank, Z.; Zhou, G.; Li, X.; Issa, N. C.; Walt, D. R.; Baden, L. R.* Soiffer, R.* Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity Post Hematopoietic Cell Transplantation, Transplantation and Cellular Therapy 2023, 29, 337.e1-337.e5.

6. Yonker, L.; Swank, Z.; Bartsch, Y.; Burns, M.; Kane, A.; Boribong, B.; Davis, J.; Loiselle, M.; Novak, T.; Senussi, Y.; Cheng, C. A.; Burgess, E.; Edlow, A.; J.; Chou, Dionne, A.; Balaguru, D.; Lahoud-Rahme, M.; Arditi, M.; Julg, B.; Randolph, A.; Alter, G.; Fasano, A.; Walt, D. R. Circulating Spike protein detected in post-COVID-19 mRNA vaccine myocarditis, Circulation 2023, 147, 867–876.

7. Duan, X.; Nie, K.*; Wang, X.; Cheng, C. A.; Zhou, R.; Hu, Z.; Yan, J.; Mei, L.; Ma, X.* Yao, S.; Wang, L.; Wang, H. Cesium manganese halide perovskite-analogue nanocrystals with highly efficient energy conversion for flexible multifunctional fibers, Inorg. Chem. Front. 2023, 10, 1338–1347.

8. Zhou, R.; Cheng, C. A.; Wang, X.; Nie, K.*; Wu, J.; Wu, M.; Duan, X.; Hu, Z.; Ul Huq I.; Wang, H.; Wang, L.*; Mei, L.; Liu. H.* Metal halide perovskite nanocrystals with enhanced photoluminescence and stability toward anti-counterfeiting high-performance flexible fibers, Nano Research, 2023, 16, 3542–3551.

9. Nie, K.*; Zhou, R.; Cheng, C. A.; Duan, X.; Hu, Z.; Mei, L.; Liu, H.; Zhang, Y.; Wang, L.; Wang, Hua; Ma, X.* Structure, luminescence properties and energy transfer of terbium and samarium co-doped barium based apatite phosphor with tunable emission colour, Heliyon 2022, 8, e12566.

10. Nie, K.*; Zhou, R.; Cheng, C. A.; Duan, X.; Hu, Z.; Mei, L.; Liu, H.; Wang, L.; Wang, Hua; Ma, X. Tb3+ and Sm3+ co-doped Ca2La3(SiO4)3F phosphor: synthesis, color regulation, and luminescence properties, RSC Adv. 2022, 12, 33200–33206.

11. Kim, K.; Narasimhan, M.; Mahimainathan, L.; Zhang, R.; Araj, E.; Kim, E.; Tharpe, W.; Greenberg, B. M.; Greenberg, D. E.; Li, Q. Z.; Cheng, C. A.; Sarode, R.; Malladi, S.;* Muthukumar, A. Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group, Front. Immunol. 2022, 13, 1020165.

12. Sherman, A. C.#; Crombie, J. L.#; Cheng, C. A.; Desjardins, M.; Zhou, G.; Ometoruwa, O.; Rooks, R.; Senussi, Y.; McDonough, M.; Guerrero, L. I.; Kupelian, J.; Doss-Gollin, S.; Smolen, K. K.; van Haren, S. D.; Armand, P.; Levy, O.; Walt, D. R.; Baden, L. R.* Issa, N. C.* Immunogenicity of a three-dose primary series of mRNA COVID-19 vaccines in patients with lymphoid malignancies, OFID 2022, ofac417.

13. Windsor, W. J.; Roell, Y.; Tucker, H.; Cheng, C. A.; Suliman, S.; Peek, L. J.; Pestano, G. A.; Lee, W. T.; Zeichhardt, H.; Lamb, M. M.; Kammel, M.; Wang, H.; Kedl, R.; Rester, C.; Morrison, T.; Davenport, B. J.; Carson, K.; Yates, J.; Howard, K.; Kulas, K.; Walt, D. R.; Dafni, A.; Taylor, D.; Chu, M. Harmonization of multiple SARS-CoV-2 Reference Materials using the WHO IS (NIBSC 20/136). Results and Implications, Front. Microbiol. 2022, 13, 893801.

14. Sherman, A. C.; Desjardins, M.; Cheng, C. A.; Bausk, B.; Izaguirre, N.; Zhou, G.; Krauss, J.; Tolan, N.; Walt, D. R.; Soiffer R.; Ho, V. T.; Issa N. C.; Baden, L. R.* Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity, Clin. Infect. Dis. 2021, 75, 920–923.

15. Gibson, C. J.; Kim, H. T.; Zhao, L.; H. Murdock, M.; Hambley, B.; Ogata, A. F.; Madero-Marroquin, R.; Wang, S.; Green, L.; Fleharty, M.; Dougan, T.; Cheng, C. A.; Blumenstiel, B.; Cibulskis, C.; Tsuji, J.; Duran, M.; Gocke, C. D.; Antin, J. H.; Nikiforow, S.; DeZern, A. E.; Chen, Y. B.; Ho, V. T.; Jones, R. J.; Lennon, N. J.; Walt, D. R.; Ritz, J.; Soiffer, R. J.; Gondek*, L. P.; Lindsley, R. C. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation, J. Clin. Oncol. 2021, 40, 189–201.

16. Langellotto, F.#; Dellacherie, M. O.#; Yeager, C.#; Liz, H.; Yu, J.; Cheng, C. A.; Dimitrakakis, N.; Seiler, B. T.; Gebre, M. S.; Gilboa, T.; Johnson, R.; Storm, N.; Bardales, S.; Graveline, A.; White, D.; Tringides, C. M.; Cartwright, M. J.; Doherty, E. J.; Honko, A.; Griffiths, A.; Barouch, D. H.; Walt, D. R.; Mooney, D. J.* A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens, Adv. Healthcare Mater. 2021, 2101370.

17. Gilboa, T.#; Cohen, L.#; Cheng, C. A.#; Lazarovits, R.#; Uwamanzu-Nna, A.; Han, I.; Griswold, K.; Barry, N.; Thompson, D. B.; Kohman, R. E.; Woolley, A. E.; Karlson, E. W.; Walt, D. R.* A SARS-CoV-2 Neutralization Assay Using Single Molecule Arrays, Angew. Chem. Int. Ed. 2021, 60, 2–9.

18. Ogata, A. F.; Lazarovits, R.; Uwamanzu-Nna, A.; Gilboa, T.; Cheng, C. A.; Walt, D. R.* Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses, Clin. Lab. Med. 2021, Vol. 42 (1) pp 97–109.

19. Zhou, R.; Cheng, C. A.; Qiu, S.; Chen, J.; Nie, K.*; Wu, M.; Lin, P.; Wang, H.*; Wang, L.; Mei L. A Novel and Facile Synthesis Strategy for Highly Stable Cesium Lead Halide Nanowires, RSC Adv. 2021, 11, 28716–28722.

20. Crombie, J. L.#; Sherman, A. C.#; Cheng, C. A.; Ryan, C. E.; Zon, R.; Desjardins, M.; Baker, P.; McDonough, M.; Izaguirre, N.; Bausk, B.; Krauss, J.; Gilboa, T.; Senussi, Y.; Walt, D. R.; Davids, M. S.; Brown, J. R.; Armand, P.; Baden, L. R.*; Issa, N.* Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies, Blood Adv. 2021, 5, 3062–3065.

21. Ogata, A. F.#; Cheng, C. A.#; Desjardins, M.#; Senussi, Y.; Sherman, A. C.; Powell, M.; Novack, L.; Von, S.; Li, X.; Baden, L. R.*; Walt, D. R.* Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients, Clin. Infect. Dis. 2021, 74, 715–718.

22. Chen, W.; Cheng, C. A.; Xiang, D.; Zink, J. I.* Expanding Nanoparticle Multifunctionality: Size-Selected Cargo Release and Multiple Logic Operations, Nanoscale 2021, 13, 5497–5506.

23. Cheng, C. A.; Chen, W.; Zhang, L.; Wu, H.*; Zink, J. I.* Magnetic Resonance Imaging of High-Intensity Focused Ultrasound-Stimulated Drug Release from a Self-Reporting Core@Shell Nanoparticle Platform, Chem. Commun. 2020, 56, 10297–10300.

24. Sun D. L.; Poddar S.; Pan R. D.; Rosser E. W.; Abt E. R.; Valkenburgh J. V.; Le T. M.; Lok V.; Hernandez S. P.; Song J.; Li J.; Turlik A.; Chen X.; Cheng, C. A.; Chen, W.; Mona C. E.; Stuparu A. D.; Vergnes L.; Reue K.; Damoiseaux R.; Zink, J. I.; Czernin J.; Donahue T. R.; Houk K. N.; Jung M. E.*; Radu C. G.* Isoquinoline Thiosemicarbazone Displays Potent Anticancer Activity with In Vivo Efficacy Against Aggressive Leukemias, RSC Med. Chem. 2020, 11, 392–410.

25. Cheng, C. A.#; Chen, W.#; Zhang, L.; Wu, H.*; Zink, J. I.* A Responsive Mesoporous Silica Nanoparticle Platform for Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound-Stimulated Cargo Delivery with Controllable Location, Time, and Dose, J. Am. Chem. Soc. 2019, 141, 17670–17684.

26. Chen, W.#; Cheng, C.A.#; Cosco, E. D.#; Ramakrishnan, S.; Lingg, J. G. P.; Bruns, O. T.*; Zink, J. I.*; Sletten, E. M.* Shortwave Infrared Imaging With J-aggregates Stabilized in Hollow Mesoporous Silica Nanoparticles, J. Am. Chem. Soc. 2019, 141, 12475–12480.

27. Cheng, C. A.; Deng, T.; Lin, F. C.; Cai, Y.; Zink, J. I.* Supramolecular Nanomachines as Stimuli-Responsive Gatekeepers on Nanoparticles for Antibiotic and Cancer Drug Delivery, Theranostics 2019, 9, 3341−3364. (Selected as back cover)

28. Ray, S.; Cheng, C. A.; Chen, W.; Li, Z. Zink, J. I.*, Lin, Y. Y.* Magnetic Heating Stimulated Cargo Release with Dose Control using Multifunctional MR and Thermosensitive Liposome, Nanotheranostics 2019, 3, 166–178. (Selected as front cover)

29. Chen, W.#; Cheng, C. A.#; Zink, J. I.* Spatial, Temporal, and Dose Control of Drug Delivery using Non-invasive Magnetic Stimulation, ACS Nano 2019, 13, 1292–1308.

30. Chen, W.#; Cheng, C. A.#; Lee, B. Y.; Clemens, D. L.; Huang, W. Y.; Horwitz, M. A.; Zink, J. I.* Facile Strategy Enabling Both High Loading and High Release Amounts of the Water-Insoluble Drug Clofazimine Using Mesoporous Silica Nanoparticles, ACS Appl. Mater. Interfaces 2018, 10, 31870−31881.

31. Kumar, N.; Chen, W.; Cheng, C. A.; Deng, T.; Wang, R.; Zink, J. I.* Stimuli-Responsive Nanomachines and Caps for Drug Delivery. In Enzymes; Tamanoi, F.; Elesvier: Oxford, UK, 2018; Vol. 43, pp 31-65.

32. Hui, Y. Y.*; Cheng, C. A.; Chen, O. Y.; Chang, H. C.* Bioimaging and Quantum Sensing Using NV Centers in Diamond Nanoparticles. In Carbon Nanoparticles and Nanostructures; Yang, N., Jiang, X., Pang, D.W. Eds.; Springer: Cham, Switzerland, 2016; pp 109-137.

33. Wu, T. J.#; Tzeng, Y. K.#; Chang, W. W.; Cheng, C. A.; Kuo. Y.; Chien, C. H.; Chang, H. C.*; Yu, J.* Tracking the Engraftment and Regenerative Capabilities of Transplanted Lung Stem Cells Using Fluorescent Nanodiamonds, Nat. Nanotechnol. 2013, 8, 682–689.

34. Fang, C. Y.#; V, V.#; Cheng, C. A.#; Yeh, S. H.; Chang, C. F.; Li, C. L.; Chang, H. C.* The Exocytosis of Fluorescent Nanodiamond and Its Use as a Long-Term Cell Tracker, Small 2011, 7, 3363–3370.